Concourse Financial Group Securities, Inc. Entrada Therapeutics, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
16 transactions
Others Institutions Holding TRDA
# of Institutions
108Shares Held
28.7MCall Options Held
15.7KPut Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$33.6 Million0.33% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$30.3 Million67.92% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.31MShares$29.8 Million19.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.57MShares$17.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$11.7 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $217M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...